Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 732

1.

Autologous mesenchymal stem cells: Hope for patients with multiple system atrophy?

Krismer F, Poewe W, Seppi K.

Neurology. 2019 May 31. pii: 10.1212/WNL.0000000000007721. doi: 10.1212/WNL.0000000000007721. [Epub ahead of print] No abstract available.

PMID:
31152012
2.

Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study).

Peball M, Werkmann M, Ellmerer P, Stolz R, Valent D, Knaus HG, Ulmer H, Djamshidian A, Poewe W, Seppi K.

J Neural Transm (Vienna). 2019 May 25. doi: 10.1007/s00702-019-02021-z. [Epub ahead of print]

PMID:
31129719
3.

Smelling Parkinson's Disease: New Metabolomic Biomarker for PD.

Poewe W.

ACS Cent Sci. 2019 Apr 24;5(4):575-576. doi: 10.1021/acscentsci.9b00319. Epub 2019 Apr 3. No abstract available.

4.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Apr 29. doi: 10.1002/mds.27701. [Epub ahead of print] No abstract available.

PMID:
31034671
5.

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.

Krismer F, Seppi K, Göbel G, Steiger R, Zucal I, Boesch S, Gizewski ER, Wenning GK, Poewe W, Scherfler C.

Mov Disord. 2019 Mar 28. doi: 10.1002/mds.27669. [Epub ahead of print]

PMID:
30919495
6.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Mar 18. doi: 10.1002/mds.27666. [Epub ahead of print]

PMID:
30884545
7.

Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study.

Reich MM, Horn A, Lange F, Roothans J, Paschen S, Runge J, Wodarg F, Pozzi NG, Witt K, Nickl RC, Soussand L, Ewert S, Maltese V, Wittstock M, Schneider GH, Coenen V, Mahlknecht P, Poewe W, Eisner W, Helmers AK, Matthies C, Sturm V, Isaias IU, Krauss JK, Kühn AA, Deuschl G, Volkmann J.

Brain. 2019 May 1;142(5):1386-1398. doi: 10.1093/brain/awz046.

PMID:
30851091
8.

Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease.

Fanciulli A, Goebel G, Lazzeri G, Scherfler C, Gizewski ER, Granata R, Kiss G, Strano S, Colosimo C, Pontieri FE, Kaufmann H, Seppi K, Poewe W, Wenning GK.

Mov Disord. 2019 Mar;34(3):440-441. doi: 10.1002/mds.27635. Epub 2019 Feb 20. No abstract available.

PMID:
30788854
9.

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares-da-Silva P.

Eur J Neurol. 2019 Jul;26(7):953-960. doi: 10.1111/ene.13914. Epub 2019 Mar 25.

PMID:
30681754
10.

Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.

Poewe W, Chaudhuri KR, Bergmann L, Antonini A.

Neurodegener Dis Manag. 2019 Feb;9(1):39-46. doi: 10.2217/nmt-2018-0034. Epub 2018 Dec 14.

11.

Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Oct 25;5(5):479-491. doi: 10.1002/mdc3.12636. eCollection 2018 Sep-Oct. Review.

PMID:
30515437
12.

The role of exposure to pesticides in the etiology of Parkinson's disease: a 18F-DOPA positron emission tomography study.

Djaldetti R, Steinmetz A, Rigbi A, Scherfler C, Poewe W, Roditi Y, Greenbaum L, Lorberboym M.

J Neural Transm (Vienna). 2019 Feb;126(2):159-166. doi: 10.1007/s00702-018-1951-8. Epub 2018 Nov 13.

PMID:
30426251
13.

Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel.

Ray Chaudhuri K, Antonini A, Robieson WZ, Sanchez-Soliño O, Bergmann L, Poewe W; GLORIA study co-investigators.

Eur J Neurol. 2019 Apr;26(4):581-e43. doi: 10.1111/ene.13847. Epub 2018 Dec 26.

PMID:
30353942
14.

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.

Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O.

Mov Disord. 2018 Oct;33(10):1528-1539. doi: 10.1002/mds.27475. Epub 2018 Sep 27. Review.

PMID:
30264443
15.

Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial.

Gruber D, Südmeyer M, Deuschl G, Falk D, Krauss JK, Mueller J, Müller JU, Poewe W, Schneider GH, Schrader C, Vesper J, Volkmann J, Winter C, Kupsch A, Schnitzler A; DBS study group for dystonia.

Brain Stimul. 2018 Nov - Dec;11(6):1368-1377. doi: 10.1016/j.brs.2018.08.006. Epub 2018 Sep 11.

PMID:
30249417
16.

Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study.

Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, Stockner H, de Marzi R, Heim B, Djamshidian A, Willeit P, Willeit J, Kiechl S, Valent D, Krismer F, Wenning GK, Nocker M, Mair K, Poewe W, Seppi K.

Gerontology. 2019;65(3):216-228. doi: 10.1159/000492572. Epub 2018 Sep 10.

PMID:
30199864
17.

Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport® ).

Simonetta-Moreau M, Picaut P, Volteau M, Poewe W.

Eur J Neurol. 2019 Jun;26(6):943-e65. doi: 10.1111/ene.13800. Epub 2018 Sep 30.

PMID:
30168896
18.

Movement disorder society criteria for clinically established early Parkinson's disease.

Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB.

Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.

PMID:
30145841
19.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

PMID:
30145797
20.

Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy.

Krismer F, Seppi K, Wenning GK, Papapetropoulos S, Abler V, Goebel G, Schocke M, Poewe W.

Parkinsonism Relat Disord. 2019 Jan;58:23-27. doi: 10.1016/j.parkreldis.2018.08.004. Epub 2018 Aug 7.

PMID:
30145124
21.

Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features.

Ray Chaudhuri K, Poewe W, Brooks D.

Mov Disord. 2018 Jul;33(6):909-919. doi: 10.1002/mds.27386. Review.

PMID:
30134055
22.

The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature.

Indelicato E, Nachbauer W, Karner E, Eigentler A, Wagner M, Unterberger I, Poewe W, Delazer M, Boesch S.

Eur J Neurol. 2019 Jan;26(1):66-e7. doi: 10.1111/ene.13765. Epub 2018 Sep 3.

PMID:
30063100
23.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A.

Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25.

PMID:
30055903
24.

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy.

Kallab M, Herrera-Vaquero M, Johannesson M, Eriksson F, Sigvardson J, Poewe W, Wenning GK, Nordström E, Stefanova N.

Front Neurosci. 2018 Jul 4;12:452. doi: 10.3389/fnins.2018.00452. eCollection 2018.

25.

Autonomic function testing in Friedreich's ataxia.

Indelicato E, Fanciulli A, Ndayisaba JP, Nachbauer W, Eigentler A, Granata R, Wanschitz J, Poewe W, Wenning GK, Boesch S.

J Neurol. 2018 Sep;265(9):2015-2022. doi: 10.1007/s00415-018-8946-0. Epub 2018 Jun 27.

26.

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.

Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR; European MSA Study Group (EMSA-SG).

Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8.

PMID:
29910157
27.

Reader response: Olfaction and incident Parkinson disease in US white and black older adults.

Mahlknecht P, Kiechl S, Willeit J, Poewe W, Seppi K.

Neurology. 2018 May 15;90(20):940. doi: 10.1212/WNL.0000000000005511. No abstract available.

PMID:
29759998
28.

Sensor-based gait analysis in atypical parkinsonian disorders.

Raccagni C, Gaßner H, Eschlboeck S, Boesch S, Krismer F, Seppi K, Poewe W, Eskofier BM, Winkler J, Wenning G, Klucken J.

Brain Behav. 2018 Jun;8(6):e00977. doi: 10.1002/brb3.977. Epub 2018 May 7.

29.

Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.

Ferreira JJ, Lees AJ, Poewe W, Rascol O, Rocha JF, Keller B, Soares-da-Silva P.

Neurology. 2018 May 22;90(21):e1849-e1857. doi: 10.1212/WNL.0000000000005557. Epub 2018 Apr 25.

PMID:
29695590
30.

The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.

Mueller C, Hussl A, Krismer F, Heim B, Mahlknecht P, Nocker M, Scherfler C, Mair K, Esterhammer R, Schocke M, Wenning GK, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2018 Sep;54:90-94. doi: 10.1016/j.parkreldis.2018.04.005. Epub 2018 Apr 3.

31.

Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.

Antonini A, Robieson WZ, Bergmann L, Yegin A, Poewe W.

Neurodegener Dis Manag. 2018 Jun;8(3):161-170. doi: 10.2217/nmt-2017-0046. Epub 2018 Apr 10.

32.

Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.

Skorvanek M, Martinez-Martin P, Kovacs N, Zezula I, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Aviles-Olmos I, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Valkovic P, Goetz CG, Stebbins GT.

Parkinsonism Relat Disord. 2018 Jul;52:83-89. doi: 10.1016/j.parkreldis.2018.03.027. Epub 2018 Mar 28.

PMID:
29625875
33.

Reflection impulsivity perceptual decision-making in patients with restless legs syndrome.

Heim B, Pertl MT, Stefani A, Heidbreder A, Zamarian L, Brandauer E, Averbeck B, Delazer M, Seppi K, Högl B, Poewe W, Djamshidian A.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):315-322. doi: 10.1002/acn3.535. eCollection 2018 Mar.

34.

Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy.

Stefani A, Heidbreder A, Brandauer E, Guaita M, Neier LM, Mitterling T, Santamaria J, Iranzo A, Videnovic A, Trenkwalder C, Sixel-Döring F, Wenning GK, Chade A, Poewe W, Gershanik OS, Högl B.

Sleep. 2018 Jun 1;41(6). doi: 10.1093/sleep/zsy053.

35.

Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.

Seki M, Seppi K, Mueller C, Potrusil T, Goebel G, Reiter E, Nocker M, Steiger R, Wildauer M, Gizewski ER, Wenning GK, Poewe W, Scherfler C.

Parkinsonism Relat Disord. 2018 Apr;49:81-87. doi: 10.1016/j.parkreldis.2018.02.004. Epub 2018 Feb 7.

PMID:
29463454
36.

The reorganization of functional architecture in the early-stages of Parkinson's disease.

Tuovinen N, Seppi K, de Pasquale F, Müller C, Nocker M, Schocke M, Gizewski ER, Kremser C, Wenning GK, Poewe W, Djamshidian A, Scherfler C, Seki M.

Parkinsonism Relat Disord. 2018 May;50:61-68. doi: 10.1016/j.parkreldis.2018.02.013. Epub 2018 Feb 8.

PMID:
29449186
37.

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.

Mahlknecht P, Gasperi A, Djamshidian A, Kiechl S, Stockner H, Willeit P, Willeit J, Rungger G, Poewe W, Seppi K.

Mov Disord. 2018 Mar;33(3):405-413. doi: 10.1002/mds.27281. Epub 2018 Feb 13.

PMID:
29436728
38.

Autonomic function testing in spinocerebellar ataxia type 2.

Indelicato E, Fanciulli A, Ndayisaba JP, Nachbauer W, Granata R, Wanschitz J, Wagner M, Gizewski ER, Poewe W, Wenning GK, Boesch S.

Clin Auton Res. 2018 Jun;28(3):341-346. doi: 10.1007/s10286-018-0504-4. Epub 2018 Feb 12.

39.

Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.

Refolo V, Bez F, Polissidis A, Kuzdas-Wood D, Sturm E, Kamaratou M, Poewe W, Stefanis L, Angela Cenci M, Romero-Ramos M, Wenning GK, Stefanova N.

Acta Neuropathol Commun. 2018 Jan 3;6(1):2. doi: 10.1186/s40478-017-0504-y.

40.

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis.

Bajaj S, Krismer F, Palma JA, Wenning GK, Kaufmann H, Poewe W, Seppi K.

PLoS One. 2017 Dec 29;12(12):e0189897. doi: 10.1371/journal.pone.0189897. eCollection 2017. Review.

41.

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, Biedenharn J, Bitan G, Brooks DJ, Brundin P, Fernandez H, Fortier P, Freeman R, Gasser T, Hewitt A, Höglinger GU, Huentelman MJ, Jensen PH, Jeromin A, Kang UJ, Kaufmann H, Kellerman L, Khurana V, Klockgether T, Kim WS, Langer C, LeWitt P, Masliah E, Meissner W, Melki R, Ostrowitzki S, Piantadosi S, Poewe W, Robertson D, Roemer C, Schenk D, Schlossmacher M, Schmahmann JD, Seppi K, Shih L, Siderowf A, Stebbins GT, Stefanova N, Tsuji S, Sutton S, Zhang J.

Neurology. 2018 Jan 9;90(2):74-82. doi: 10.1212/WNL.0000000000004798. Epub 2017 Dec 13. Review.

42.

SOX5-Null Heterozygous Mutation in a Family with Adult-Onset Hyperkinesia and Behavioral Abnormalities.

Zech M, Poustka K, Boesch S, Berutti R, Strom TM, Grisold W, Poewe W, Winkelmann J.

Case Rep Genet. 2017;2017:2721615. doi: 10.1155/2017/2721615. Epub 2017 Oct 29.

43.

MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.

Mangesius S, Hussl A, Krismer F, Mahlknecht P, Reiter E, Tagwercher S, Djamshidian A, Schocke M, Esterhammer R, Wenning G, Müller C, Scherfler C, Gizewski ER, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2018 Jan;46:47-55. doi: 10.1016/j.parkreldis.2017.10.020. Epub 2017 Oct 31.

44.

Parkinson's disease and the quest for preclinical diagnosis: an interview with Professor Werner Poewe.

Poewe W.

Neurodegener Dis Manag. 2017 Oct;7(5):273-277. doi: 10.2217/nmt-2017-0027. Epub 2017 Oct 18.

45.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

46.

Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis.

Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, Dauvilliers Y, Stefani A, Högl B, Poewe W, Kemlink D, Sonka K, Bachmann CG, Paulus W, Trenkwalder C, Oertel WH, Hornyak M, Teder-Laving M, Metspalu A, Hadjigeorgiou GM, Polo O, Fietze I, Ross OA, Wszolek Z, Butterworth AS, Soranzo N, Ouwehand WH, Roberts DJ, Danesh J, Allen RP, Earley CJ, Ondo WG, Xiong L, Montplaisir J, Gan-Or Z, Perola M, Vodicka P, Dina C, Franke A, Tittmann L, Stewart AFR, Shah SH, Gieger C, Peters A, Rouleau GA, Berger K, Oexle K, Di Angelantonio E, Hinds DA, Müller-Myhsok B, Winkelmann J; 23andMe Research Team; DESIR study group.

Lancet Neurol. 2017 Nov;16(11):898-907. doi: 10.1016/S1474-4422(17)30327-7. Review.

47.

Levodopa and Parkinson Disease-Myths Revisited.

Lim SY, Poewe W, Tan AH.

JAMA Neurol. 2017 Oct 1;74(10):1270. doi: 10.1001/jamaneurol.2017.2560. No abstract available.

PMID:
28973082
48.

Caveats of Neurodegenerative Risk Stratification in Idiopathic REM Sleep Behavior Disorder by Use of the MDS Research for Prodromal Parkinson's Disease.

Mahlknecht P, Iranzo A, Stefani A, Serradell M, Santamaria J, Tolosa E, Högl B, Poewe W.

Sleep. 2017 Oct 1;40(10). doi: 10.1093/sleep/zsx131. No abstract available.

PMID:
28958020
49.

Response to: On the role of visual electrophysiology in parkinson's disease.

Janssen S, Ekker MS, Poewe W, van Wezel RJA, Nonnekes J, Bloem BR.

Parkinsonism Relat Disord. 2017 Dec;45:98. doi: 10.1016/j.parkreldis.2017.09.004. Epub 2017 Sep 7. No abstract available.

PMID:
28919149
50.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

Supplemental Content

Support Center